Skip to main content
. 2020 Mar 24;11:512. doi: 10.3389/fimmu.2020.00512

Figure 1.

Figure 1

Versican increases in the extracellular matrix (ECM) as part of the early inflammatory response. Immune cells invade the tissue from the blood stream and interact with specific ECM components including versican, versican fragments such as versikine (generated by versicanases), and other ECM components that associate with versican. This interaction may involve receptors on the immune cells such as CD44, P-selectin glycoprotein 1 (PSGL-1), receptor for hyaluronan-mediated motility (RHAMM), and toll-like receptors (TLRs). This interaction impacts several aspects of immune cell activation as part of the immune and inflammatory response.